Related Experiment Video
Updated: Jul 9, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Akt in the pathogenesis of COPD
Steven Bozinovski1, Ross Vlahos, Michelle Hansen
1The Lung Disease Research Laboratories, Cooperative Research Centre for Chronic Inflammatory Diseases, Department of Pharmacology, The University of Melbourne, VIC, Australia. bozis@unimelb.edu.au
International Journal of Chronic Obstructive Pulmonary Disease
|December 1, 2007
Summary
Targeting Akt, a key protein kinase, shows therapeutic potential for chronic obstructive pulmonary disease (COPD). Both Akt inhibitors and activators may treat distinct COPD patient groups.
Area of Science:
- Biochemistry
- Molecular Biology
- Pulmonology
Background:
- Chronic obstructive pulmonary disease (COPD) involves persistent inflammation and systemic manifestations.
- Akt (also known as Protein Kinase B) is a central signaling molecule regulating cell survival, inflammation, and growth.
- Akt integrates signals from various stimuli implicated in COPD pathogenesis.
Purpose of the Study:
- To review the therapeutic potential of targeting Akt for COPD treatment.
- To explore Akt's role in COPD pathogenesis and systemic complications.
- To evaluate Akt as a potential therapeutic target for COPD.
Main Methods:
- Review of existing literature on Akt signaling in COPD.
- Analysis of Akt's involvement in inflammatory pathways.
- Examination of Akt's role in COPD-related systemic effects like muscle wasting.
Main Results:
- Persistent Akt activation, potentially due to mutations (e.g., in PTEN), may drive unresolved inflammation in COPD.
- Akt is implicated in skeletal muscle wasting and metabolic disturbances associated with COPD.
- Targeting Akt could mitigate the severity and duration of COPD exacerbations.
Conclusions:
- Akt is a promising therapeutic target for COPD.
- Both Akt inhibitors and activators may offer treatment strategies for different COPD patient subpopulations.
- Further research into Akt-targeted therapies could significantly impact COPD management.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...